<DOC>
	<DOCNO>NCT00169416</DOCNO>
	<brief_summary>This study ass safety efficacy , pharmacokinetics aciclovir valaciclovir child chickenpox follow oral administration valaciclovir , purpose seek approval valaciclovir HCl treatment chickenpox .</brief_summary>
	<brief_title>Evaluation Of Valaciclovir In Patients With Chickenpox</brief_title>
	<detailed_description />
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion criterion : Subjects age 1 year less 12 year clinical diagnosis chickenpox within 48 hour onset rash . Exclusion criterion : History hypersensitivity reaction . Impaired hepatic renal function . Gastrointestinal dysfunction . Serious underlying disease . Weigh 40kg . Vaccinated chickenpox .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>chicken pox</keyword>
	<keyword>varicella</keyword>
	<keyword>VZV</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>